Nicotinamide riboside supplement for chronic kidney disease
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether a daily supplement called nicotinamide riboside (a form of vitamin B3) can help people with moderate chronic kidney disease. It aims to see if it can slow down kidney function decline and improve overall health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate chronic kidney disease (not requiring dialysis), with a certain kidney function level.
- Your urine albumin-to-creatinine ratio is less than 300 mg/g.
- You can walk from room to room without help (a walker or cane is okay if approved).
- You are not pregnant, don't have certain serious liver or lung diseases, and don't have HIV.
- You haven't been hospitalized for heart issues or stroke in the last 3 months.
- You are not currently in another trial and not taking immune-suppressing drugs like steroids.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a supplement called nicotinamide riboside (a form of vitamin B3) can help protect your kidneys during heart valve surgery. You may qualify if you are scheduled for this surgery and meet a few health requirements.
This study tests whether nicotinamide riboside (a B-vitamin supplement) can help people with combined pulmonary hypertension—a condition where blood pressure in the lungs is too high. The researchers want to understand how this supplement affects the body's energy metabolism and whether it might reduce symptoms and improve heart function.
This study tests whether a daily supplement called nicotinamide riboside (a form of vitamin B3), combined with a supervised exercise program, can help promote healthy aging and improve how well your body functions. You would take the supplement or a placebo for 12 weeks while doing light to moderate exercise.
This trial tests whether a daily supplement called nicotinamide riboside can help older adults who feel weak or frail to get stronger and more energetic. It lasts for several months and involves simple tests like a walking test and memory checks.
This study tests whether a supplement called nicotinamide riboside (a form of vitamin B3) can improve walking ability in people with peripheral artery disease (PAD), a condition that causes leg pain when walking due to poor blood flow. It is a phase 3 trial, meaning it's in the final stages of testing before possible approval.
This trial tests whether nicotinamide riboside can improve elevated blood pressure and blood vessel stiffness in middle-aged and older adults. You may be randomly assigned to take the study medicine or not, and the team will check your heart/blood vessel measurements over time.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.